# HGLG11 Analysis üî¥
**Date:** 2026-01-29
**Sentiment:** Cautious (-0.2)
**Trend:** Sideways

## üö® Key Events
- **Vacancy Increase** (Negative): Physical vacancy increased to 2.4% at the end of November 2025 and is projected to reach 4.5% by the end of February 2026.
- **Tenant Exits** (Negative): Multiple tenants exited properties, including Roja and Eletrobras (Syslog), Memodoc (Duque de Caxias), Plastic Omnium (S√£o Jos√©), with √äxito (Syslog), TLS (CLE), and RV Imola (Ribeir√£o Preto) expected to exit in January and February 2026.
- **New Tenant** (Positive): Knight Therapeutics to enter Masterlabs in December 2025.
- **Consistent Dividends** (Neutral): R$ 1.10 per share dividend has been consistently paid for the last 30 months, with the next dividend also at R$1.1, ex-date February 03, 2026.
- **Property Revaluation** (Positive): Property revaluation showed an average increase of 2.52% compared to the accounting values of December 2024.

## üìù Detailed Summary
HGLG11 faces increasing vacancy, rising to 2.4% in November 2025 and projected to 4.5% by February 2026. Tenant exits include Roja, Eletrobras (Syslog), Memodoc (Duque de Caxias), and Plastic Omnium (S√£o Jos√©), with further exits expected in January and February 2026. Knight Therapeutics will enter Masterlabs in December 2025. The fund has consistently paid R$1.10 per share in dividends for 30 months, with the next dividend at the same value (ex-date February 03, 2026). Property revaluation showed a 2.52% increase compared to December 2024 values.